1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Scientific review
-
Mark
Evaluation of a Sensitive Visual Read Algorithm for Assessing 3R/4R Tau PET Images
(2025) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 66(11). p.1764-1770
- Contribution to journal › Article
- 2023
-
Mark
Tau pathology as determinant of changes in atrophy and cerebral blood flow : a multi-modal longitudinal imaging study
- Contribution to journal › Article
-
Mark
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum
- Contribution to journal › Article
- 2021
-
Mark
Time between milestone events in the Alzheimer's disease amyloid cascade
- Contribution to journal › Article
-
Mark
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
- Contribution to journal › Article
-
Mark
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
- Contribution to journal › Scientific review
